Guangyao Group describes AI drug research platform; Huawei outlines AI wildlife monitoring projectsMachine translation

Guangyao Group said it worked with Huawei on an AI drug research platform spanning discovery through registration and launch, shortening early drug candidate development from 12–18 months to 1–3 months. Huawei also described an AI pilot for monitoring human–bear conflict in Shennongjia and a behavior recognition system for Yangtze finless porpoise conservation.